Teleflex Signs New Agreement with HealthTrust for Arrow Intra-Aortic Balloon Pumps and Catheters

LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust Purchasing Group, L.P., (HealthTrust), for its Arrow® Intra-Aortic Balloon Pump and Catheter products. The new agreement begins March 1, 2012 and extends through February 28, 2015. HealthTrust is a group purchasing organization supporting nearly 1,400 not-for-profit and for-profit acute care facilities, as well as 10,600 ambulatory surgery centers, physician practices and alternate care sites.

Teleflex, through its Arrow Cardiac Care Products, offers intra-aortic balloon (IAB) catheter and intra-aortic balloon pump (IABP) products. The AutoCAT2 WAVE® pump, combined with Arrow’s FiberOptix® IAB catheter, offers ProActive CounterPulsation®. Through the unique, patented WAVE® timing algorithm, converting arterial pressure to aortic flow, combined with the AutoCAT® 2’s Deflation Timing Management and second generation AutoPilot™ mode of operation, the intra-aortic balloon pump system enables the clinician to support even the most challenging heart rhythms with 98 percent timing accuracy. In addition, Teleflex’s Cardiac Care division offers conventional catheters, ranging from polyurethane to wire-reinforced catheter bodies in a variety of balloon membrane sizes to match physician preference and patient need. The AutoCAT2 series also offers a smaller and lighter weight pump configuration for situations where pump weight is important, such as during helicopter transport of critically ill cardiac patients who require IABP support.

“Arrow Intra-Aortic Balloon Pump and Catheter products have developed an outstanding reputation for excellent quality and innovation with clinicians throughout the world,” said Howard Miller, president, Cardiac Care Division. “We are proud to be a contracted partner with HealthTrust and look forward to the new opportunities this agreement brings to serve HealthTrust members and their patients.”

About HealthTrust

HealthTrust Purchasing Group, L.P., headquartered in Brentwood, Tenn., is a group purchasing organization that supports nearly 1,400 not-for-profit and for-profit acute care facilities, as well as 10,600 ambulatory surgery centers, physician practices and alternate care sites. With an annual purchasing volume by its members of more than $20 billion, HealthTrust is committed to obtaining the best price for clinically recommended products, ensuring their timely delivery, and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. The website is www.healthtrustpg.com.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 130 countries. Additional information about Teleflex can be obtained from the company's website at http://www.teleflex.com.

Teleflex, Arrow, AutoCAT, AutoCAT2 WAVE, WAVE, FiberOptix, ProActive CounterPulsation and AutoPilot are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.



CONTACT:

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:   Surgery  Health  Cardiology  Hospitals  Medical Devices

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.